Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


Epoxide hydrolase inhibitor
BML-EI392-0010 10 mg 61.00 USD
BML-EI392-0050 50 mg 301.00 USD
Do you need bulk/larger quantities?
Novel inhibitor of soluble epoxide hydrolase (IC50=18nM and 69nM for the mouse and human enzymes respectively). Produces a hypotensive effect in angiotensin-infused rats and prevents and reverses cardiac hypertrophy in mouse models of cardiac hypertrophy.

Product Details

Alternative Name:12-(3-Adamantan-1-yl-ureido)-dodecanoic acid
Purity:≥98% (TLC)
Appearance:White solid.
Solubility:Soluble in DMSO (10mg/ml) or 100% ethanol (4mg/ml).
Long Term Storage:-20°C
Use/Stability:Store solutions at -20°C for up to 3 months.
Regulatory Status:RUO - Research Use Only
Please mouse over

Product Literature References

Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors: D. Xu, et al.; PNAS U.S.A. 103, 18733 (2006), Abstract;
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension: J.D. Imig, et al.; Hypertension 46, 975 (2005), Abstract;
Structural refinement of inhibitors of urea-based soluble epoxide hydrolases: C. Morisseau, et al.; Biochem. Pharmacol. 63, 1599 (2002), Abstract;

Related Literature

Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Download as PDF

All new literature pieces

Recommend this page

Keep in touch

©2022 Enzo Life Sciences, Inc.,